Clinical Trial Update: SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a SALIRI-based regimen as first-line treatment for advanced metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SALIRI-based regimen

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Advanced Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN